A main concern about the surgical treatment of BRCA1/BRCA2 mutations breast cancers is whether breast conserving surgery (BCS) combined with radiotherapy is equivalent to radical mastectomy or not. This evidence concerns the gene BRCA1 and breast carcinoma.